Swiss Biotech Startup PANDA Therapeutics Secures €160,000 Grant from Venture Kick for Alzheimer’s Therapy
Swiss biotech startup PANDA Therapeutics received a €160,000 grant from Venture Kick to develop a first‑in‑class antibody therapy that simultaneously targets multiple harmful protein deposits in Alzheimer’s disease, aiming to improve treatment effectiveness and slow disease progression.